SEC Form 4 · accession 0001209191-16-122883
NEUROCRINE BIOSCIENCES INC · NBIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred Sandrock
Director
Period of report
May 20, 2016
Accepted (ET)
May 24, 2016 · 3:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000914475
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $47.89 | May 20, 2016 | A | 15,000 | A | Jun 20, 2016 | May 20, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Option vests in 12 equal monthly installments beginning June 20, 2016.